<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03673228</url>
  </required_header>
  <id_info>
    <org_study_id>18-00723</org_study_id>
    <nct_id>NCT03673228</nct_id>
  </id_info>
  <brief_title>Preventing Smoking Relapse After Total Joint Replacement Surgery</brief_title>
  <official_title>Preventing Smoking Relapse After Total Joint Replacement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hospitalization for elective knee or hip replacement surgery presents an outstanding&#xD;
      opportunity to motivate people to quit smoking, because it provides an opportunity to&#xD;
      encourage patients to remain smoke-free as they proactively quit to optimize their surgery&#xD;
      outcomes. This study will conduct a comparative effectiveness trial of patients who quit&#xD;
      smoking pre-operatively, comparing the current standard of care with a novel comprehensive&#xD;
      relapse prevention intervention guided by Marlatt's Relapse Prevention Model.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific aims of this study are to evaluate the effectiveness and cost-effectiveness of&#xD;
      the relapse prevention intervention and will: 1) compare the effectiveness of standard&#xD;
      post-operative cessation treatment with a comprehensive relapse prevention intervention on&#xD;
      smoking cessation outcomes; 2) conduct a comparative economic analysis to assess the value of&#xD;
      the relapse prevention intervention for patients and the healthcare system; and 3) explore&#xD;
      the impact of the interventions on surgical complications and readmissions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Actual">January 28, 2021</completion_date>
  <primary_completion_date type="Actual">January 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self Reported Relapse Rate for Usual Care Arm</measure>
    <time_frame>3 Months</time_frame>
    <description>Measured using the modified Dillman method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self Reported Relapse Rate for Usual Care Arm</measure>
    <time_frame>6 Months</time_frame>
    <description>Measured using the modified Dillman method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self Reported Relapse Rate for Usual Care Arm</measure>
    <time_frame>12 Months</time_frame>
    <description>Measured using the modified Dillman method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self Reported Relapse Rate for relapse prevention intervention arm</measure>
    <time_frame>3 Months</time_frame>
    <description>Measured using the modified Dillman method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self Reported Relapse Rate for relapse prevention intervention arm</measure>
    <time_frame>6 Months</time_frame>
    <description>Measured using the modified Dillman method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self Reported Relapse Rate for relapse prevention intervention arm</measure>
    <time_frame>12 Months</time_frame>
    <description>Measured using the modified Dillman method</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Smoking</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomized to the Intervention Arm will receive counseling that includes:&#xD;
A Visit prior to discharge&#xD;
Follow up calls after discharge&#xD;
Text Messaging Support&#xD;
Caregiver Support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive current usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comprehensive Relapse Prevention Intervention</intervention_name>
    <description>This intervention consists of 4 components:&#xD;
Visit Prior to Discharge: counselor from research team will visit patient at hospital bedside to provide counseling&#xD;
Follow up calls after discharge: 6 proactive counseling calls and initiate unlimited reactive calls to their counselor, at days 1,3,7,14,30,an 60 days after hospital visit&#xD;
Text messaging support: patients will be registered in NCI's Smokefree TXT while in the hospital and will receive multiple daily messages, designed for someone who has already quit&#xD;
Caregiver support: 10 minute training session to the caregiver on how to help patient prevent relapse by increasing self efficacy, maintaining motivation and dealing with high risk situations</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Treatment Counseling</intervention_name>
    <description>Participants will receive two 10 minute counseling calls from the staff of the preoperative counseling program during the first month after the hospital discharge</description>
    <arm_group_label>Standard treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Replacement Therapy (NRT)</intervention_name>
    <description>Patients in both arms will be encouraged to receive NRT</description>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_label>Standard treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patient Participants&#xD;
&#xD;
          -  Received preoperative smoking cessation counseling through Orthopedic Surgery Quit&#xD;
             Smoking Program&#xD;
&#xD;
          -  Undergoing elective knee or hip arthroplasty surgery&#xD;
&#xD;
          -  Have not smoked any cigarettes in the week prior to admission and carbon monoxide 4&#xD;
             ppm46,47&#xD;
&#xD;
          -  Have a cell phone (for text messaging)&#xD;
&#xD;
          -  Provide informed consent in English&#xD;
&#xD;
        Caregiver participants:&#xD;
&#xD;
          -  Age â‰¥ 18 years&#xD;
&#xD;
          -  Be a caregiver of the patient participant&#xD;
&#xD;
          -  Provide informed consent in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients will be excluded if they used smokeless tobacco or an electronic cigarette in&#xD;
             the last 30 days.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Sherman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 27, 2018</study_first_submitted>
  <study_first_submitted_qc>September 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2018</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

